Vishnu K: The Growing Role of RET-He in Modern Hematology
Vishnu K, Hematopathology Postgraduate at Nitte University, shared a post on LinkedIn:
“RET-He: Precision Anemia Management.
Early detection is the key to effective anemia management. Reticulocyte Hemoglobin Equivalent (RET-He) is emerging as a powerful biomarker that assesses the real-time availability of iron for red blood cell production—often identifying iron deficiency before changes in hemoglobin become apparent.
By enabling earlier diagnosis, monitoring response to iron therapy within days, and supporting anemia management in conditions such as chronic kidney disease, inflammation, pregnancy, and pediatric populations, RET-He is advancing a more precise and personalized approach to patient care.
As laboratory medicine continues to evolve, innovative biomarkers like RET-He are helping clinicians make faster, evidence-based decisions that improve patient outcomes.
Precision diagnostics. Timely intervention. Better patient care.”
Stay updated with Hemostasis Today.
-
Sep 27, 2026, 07:27Alexander Misono: Chronic Deep Vein Thrombosis and the Impact of Delayed Treatment
-
Sep 27, 2026, 07:17Emma Copperwaite: Back to BBTS With New Research and New Ideas
-
Sep 27, 2026, 05:58Alefiya B.: Imagine Treating a Genetic Disorder by Giving Cells the Instructions They are Missing
-
Sep 27, 2026, 04:5310 Posts Not to Miss This Week
-
Sep 27, 2026, 03:23Massimo Martino: VEN-DEC-GITMO – Advancing AML Treatment in Older Patients
-
Sep 27, 2026, 03:08Arrigo Francesco Giuseppe Cicero: Why Earlier LDL-C Lowering May Matter in Cardiovascular Prevention
-
Sep 27, 2026, 02:51Veronique Witko-Sarsat: Thromboinflammation at the 17th World Congress of Inflammation
-
Sep 27, 2026, 01:45Jin-Xiong She: Functional Iron Deficiency in the Setting of Chronic Inflammation
-
Sep 27, 2026, 01:44Crystal Karakochuk: Scientific Reports Launches New Collection on Iron Deficiency and Anemia